Chronic Myeloid Leukemia


Conference Reporter in Chronic Myeloid Leukemia to Cover Key Topics Being Presented at EHA2023 Hybrid Congress

conference reporter by Daniel J. DeAngelo, MD, PhD; Elias Jabbour, MD


Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Chronic Myeloid Leukemia presented at this year’s European Hematology Association Hybrid Congress.




  • Chronic Myeloid Leukemia at EHA2023: Clinical Roundup
  • Late-line Treatment in Chronic-Phase Chronic Myeloid Leukemia
  • Treatment-Free Remission in Chronic Myeloid Leukemia: How to Optimize Eligibility and Improve Success Rates


This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the European Hematology Association.

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Institute Physician
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA

Elias Jabbour, MD

Professor of Medicine, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX